1 completed, 1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow LISCure Biosciences: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC LB-P8 low-dose, LB-P8 high-dose, Placebo - Primary Sclerosing Cholangitis (PSC) | Phase 2 | Recruiting | LISCure Biosciences | 87 | 2025-11-01 | 2025-10-24 |
| A Study to Assess the Safety and Tolerability of LB-P6 and LB-P8 in Healthy Participants LB-P6, LB-P8, Placebo - Rheumatoid Arthritis, Non-Alcoholic Steatohepatitis | Phase 1 | Completed | LISCure Biosciences | 31 | 2022-01-04 | 2022-09-06 |
Arthritis, Rheumatoid (1) · Cholangitis, Sclerosing (1) · Cholestasis (1) · Inflammatory Bowel Diseases (1) · Non-alcoholic Fatty Liver Disease (1) · Pruritus (1)
Australia (1) · United States (1)